Acute symptomatic neonatal seizures in preterm newborns are a relevant clinical challenge due to the presence of many knowledge gaps. Etiology-wise, acute symptomatic seizures have an age-specific epidemiology, with intraventricular hemorrhage and its complications representing the first cause in extremely and very preterm neonates, whereas other etiologies have similar occurrence rates as in fullterm infants. Specific treatment strategies for the premature neonates are not yet available. Studies suggest a similarly low response rate with even more unfavorable prognosis than in full-term infants. Pharmacodynamic and pharmacokinetic changes are likely under way during the preterm period, with the potential to affect both effectiveness and safety of antiepileptic drugs in these patients. However, due to the lack of clear evidence to guide prioritization of second-line drugs, off-label medications are frequently indicated by review papers and flow-charts, and are prescribed in clinical practice. We therefore conclude by exploring potential future lines of research. (C) 2017 Elsevier Ltd. All rights reserved.

Acute symptomatic neonatal seizures in preterm neonates: etiologies and treatments / Pisani, F.; Spagnoli, C.. - In: SEMINARS IN FETAL & NEONATAL MEDICINE. - ISSN 1744-165X. - 23:3(2018), pp. 191-196. [10.1016/j.siny.2017.12.003]

Acute symptomatic neonatal seizures in preterm neonates: etiologies and treatments

Pisani, F.;
2018

Abstract

Acute symptomatic neonatal seizures in preterm newborns are a relevant clinical challenge due to the presence of many knowledge gaps. Etiology-wise, acute symptomatic seizures have an age-specific epidemiology, with intraventricular hemorrhage and its complications representing the first cause in extremely and very preterm neonates, whereas other etiologies have similar occurrence rates as in fullterm infants. Specific treatment strategies for the premature neonates are not yet available. Studies suggest a similarly low response rate with even more unfavorable prognosis than in full-term infants. Pharmacodynamic and pharmacokinetic changes are likely under way during the preterm period, with the potential to affect both effectiveness and safety of antiepileptic drugs in these patients. However, due to the lack of clear evidence to guide prioritization of second-line drugs, off-label medications are frequently indicated by review papers and flow-charts, and are prescribed in clinical practice. We therefore conclude by exploring potential future lines of research. (C) 2017 Elsevier Ltd. All rights reserved.
2018
Acute symptomatic; Etiology; Neonatal seizures; Newborn; Preterm; Therapy; Treatment
01 Pubblicazione su rivista::01a Articolo in rivista
Acute symptomatic neonatal seizures in preterm neonates: etiologies and treatments / Pisani, F.; Spagnoli, C.. - In: SEMINARS IN FETAL & NEONATAL MEDICINE. - ISSN 1744-165X. - 23:3(2018), pp. 191-196. [10.1016/j.siny.2017.12.003]
File allegati a questo prodotto
File Dimensione Formato  
1-s2.0-S1744165X17301440-main.pdf

solo gestori archivio

Note: Pisani_Acute symptomatic neonatal seizures_2018
Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 342.17 kB
Formato Adobe PDF
342.17 kB Adobe PDF   Contatta l'autore

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1674084
Citazioni
  • ???jsp.display-item.citation.pmc??? 2
  • Scopus 16
  • ???jsp.display-item.citation.isi??? 14
social impact